Go back

Funders fear return to ‘fragmented’ disease research

   

Pandemic cooperation could wither due to “Infectious Nationalism” or back to normal scenarios, says Glopid-R

As scientists around the world are praised for working together internationally to fight Covid-19, the head of a major network of funding organisations has warned of the risks of a ‘back to normal’ situation of uncoordinated global disease research.

There is “a clear need for greater coordination and efficiency to address the current pandemic as well as future pandemics”, said Charu Kaushic, chair of the Glopid-R group—which includes large R&D funders such as the European Commission, UK-based charity the Wellcome Trust, the South African Medical Research Council and the US-based Bill and Melinda Gates Foundation.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.